Tumor Microenvironment Analysis of Prostate Cancer Metastasis

Part of paid clinical trials in New York, New York.

Sponsor
Columbia University
Study ID
NCT05304858
Status
Recruiting
Apply to this trial

Conditions

  • Recurrent Prostate Cancer

Eligibility Criteria

Sex
MALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Biopsy — PROCEDURE
    Standard of care surgical procedures to collect prostate cancer tissue from men with metastatic prostate cancers. Non-experimental.

Study Details

The purpose of this study is to collect prostate cancer tissue from males with metastatic prostate cancers in order to study the tumor microenvironment (TME), which is the area surrounding the tumor including cells, blood vessels, etc., in men with metastatic prostate cancer. The type of research performed on these tissue samples include genetic \& molecular analyses.

Key Dates

Start date
Sep 15, 2021
Status verified
Jun 2026
Primary completion
Feb 29, 2028
Completion
Feb 29, 2028

Study Design

Enrollment
16 participants (estimated)

Arms

  • Arm: TME Analysis
    Participants who have been diagnosed with metastatic castration-resistant prostate cancer (mCRPC) will volunteer for a biopsy of a site in the body that contains prostate cancer, such as a bone, a lymph node or an organ such as the liver OR are planned to undergo standard of care surgical procedures such as orthopedic surgery or neurosurgery based on a subjects clinical needs.

Primary Outcome Measure

Single-Cell RNA Sequencing (scRNAseq) [ Time Frame: 2 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Columbia University Irving Medical CenterNew YorkNew York10032
Research Nurse Navigator
[email protected]
212-342-5162

Find similar trials in New York, NY

By research site
Columbia University Irving Medical Center· New York, NY

Related Studies